Search documents
2024年港股18A:生物科技行业洞察报告:医疗器械赛道(上)-寒冬困境下,医疗器械行业的机遇与挑战
Tou Bao Yan Jiu Yuan· 2024-09-25 12:02
Industry Investment Rating - The report does not explicitly mention an investment rating for the industry [1][2][3] Core Views - The medical device industry is undergoing high-quality development, driven by domestic substitution and technological innovation [3] - The 18A rule has provided a platform for excellent medical device companies to grow, enhancing industry vitality [3] - Centralized procurement and healthcare payment reforms are accelerating market consolidation and promoting cost-effective solutions [3] - The vascular interventional device market is growing steadily, with a total transaction volume of 21,0755 units in 2023, and a 39.3% share in Q4 [4] - The non-vascular interventional device market is expanding, with global procedures increasing from 77.1 million in 2016 to 125.1 million in 2022, and expected to reach 256.2 million by 2030 [5] - The in-vitro diagnostics (IVD) market is dominated by molecular diagnostics, immunodiagnostics, and biochemical diagnostics, with immunodiagnostics being the largest segment [6] Market Conditions by Category Vascular Interventional Devices - The vascular interventional device market saw a total transaction volume of 21,0755 units in 2023, with Q4 accounting for 39.3% of the total [4] - The total transaction amount was 14.3 billion, with Q2 accounting for 31.0% [4] Non-Vascular Interventional Devices - Global non-vascular interventional procedures increased from 77.1 million in 2016 to 125.1 million in 2022, and are expected to reach 256.2 million by 2030 [5] - In China, non-vascular interventional procedures grew from 21.1 million in 2016 to 37.6 million in 2022, and are expected to reach 89.0 million by 2030 [5] In-Vitro Diagnostics (IVD) - The IVD market is segmented into molecular diagnostics, immunodiagnostics, and biochemical diagnostics, with immunodiagnostics being the largest segment [6] - Immunodiagnostics, based on immunology principles, includes technologies like chemiluminescence, enzyme-linked immunosorbent assay (ELISA), and colloidal gold [6] Interventional Medical Devices Definition and Classification - Interventional medicine uses imaging diagnostics to guide treatments, involving minimally invasive techniques with small incisions and reduced risks [9][10] - It is divided into vascular and non-vascular interventional medicine, with applications in treating vascular diseases, tumors, and organ dysfunctions [11][12] Industry Chain - The interventional device industry chain includes upstream raw material suppliers, midstream manufacturers, and downstream healthcare institutions [13][14] - Upstream materials include medical polymers and metals, with high dependence on overseas suppliers due to stringent quality requirements [14] - Midstream manufacturers face intense competition, with multinational companies dominating the high-end market, while local companies are making breakthroughs in certain segments [14] Coronary Intervention - PCI (Percutaneous Coronary Intervention) procedures in China increased from 915,000 in 2018 to 1.636 million in 2023, with a CAGR of 12.3% [15][17] - The penetration rate of PCI in China is lower compared to developed countries, with 824.1 procedures per million population in 2021 [16] - The market size for precision PCI in China grew from 510 million in 2019 to 3.93 billion in 2023, with a CAGR of 66.6%, and is expected to reach 8.87 billion by 2028 [19][20] Neurointervention - The neurointerventional device market in China grew from 4.56 billion in 2019 to 8.25 billion in 2023, with a CAGR of 16.0%, and is expected to reach 43.22 billion by 2028 [21] - Factors driving growth include aging populations, supportive policies, and advancements in AI technology for cerebrovascular disease diagnosis and treatment [21] Peripheral Vascular Intervention - The peripheral vascular interventional device market in China grew from 3.26 billion in 2019 to 6.39 billion in 2023, with a CAGR of 18.3%, and is expected to reach 13.24 billion by 2028 [22] - The market is currently dominated by foreign companies, with domestic companies making progress in single-product breakthroughs [22] Non-Vascular Intervention - The global endoscope market for non-vascular interventions grew from 14.4 billion in 2019 to 18.7 billion in 2023, and is expected to reach 27.7 billion by 2028 [24] - In China, the market grew from 17.1 billion in 2019 to 22.8 billion in 2023, and is expected to reach 38.4 billion by 2028 [24] In-Vitro Diagnostics (IVD) Definition and Classification - IVD involves testing human samples outside the body to obtain clinical diagnostic information, with applications in disease prevention, diagnosis, and monitoring [27][28] - The market is segmented into immunodiagnostics, microbiological diagnostics, molecular diagnostics, POCT, biochemical diagnostics, and clinical laboratory diagnostics [29] Industry Chain - The IVD industry chain includes upstream raw material suppliers, midstream manufacturers, and downstream healthcare institutions [30][31] - Upstream materials include diagnostic enzymes, antigens, and antibodies, with high technical barriers and low domestic production rates [31] - Midstream manufacturers focus on R&D, production, and quality control, with international companies dominating the high-end market [33] Market Size - The IVD market in China grew from 1.185 trillion in 2019 to 2.417 trillion in 2023, with a CAGR of 19.5%, and is expected to reach 4.442 trillion by 2028 [34][35] - Key drivers include aging populations, increasing healthcare expenditures, and advancements in technology [35]
智慧教育引擎:教学仪器创新设计与精工智造领航先锋 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2024-09-25 12:01
Investment Rating - The report indicates a positive investment outlook for the educational instrument manufacturing industry, with a projected compound annual growth rate (CAGR) of 7.70% from 2024 to 2028, following a CAGR of 10.87% from 2018 to 2023 [32]. Core Insights - The educational instrument manufacturing industry is experiencing continuous market growth driven by increased educational investment, expansion of online education users, and growth in the number of compulsory education students. However, challenges such as long equipment update cycles, high entry barriers, and low market efficiency persist [4][11]. - The demand for educational instruments is expected to remain robust due to the ongoing development of China's education sector, with the number of enrolled students increasing from 276 million in 2018 to 293 million in 2023, and total educational funding rising from 4,614.3 billion RMB to 6,134.4 billion RMB during the same period [20][33]. Industry Definition - The educational instrument industry focuses on creating and providing specialized equipment and tools tailored to specific teaching needs across various educational stages and disciplines. This includes a wide range of teaching devices, general instruments, and non-specialized equipment [5]. Industry Characteristics - The educational instrument manufacturing industry is characterized by long equipment update cycles, high entry barriers, and low market efficiency. The average update cycle for educational instruments is 8 to 10 years, and many instruments are used for over a decade before replacement is considered [11][12]. Industry Development History - The educational instrument industry in China has evolved through four stages: initiation (1949-1978), turbulence (1978-1985), rapid growth (1985-2010), and the current phase of information-based balanced development (2010-present). The industry is now moving towards intelligent, personalized, and international development [14][18]. Industry Scale - The market size of the educational instrument manufacturing industry grew from 960 billion RMB in 2018 to 1,600 billion RMB in 2023, with a CAGR of 10.87%. It is projected to reach 2,390 billion RMB by 2028 [32][33]. Policy Overview - Recent policies emphasize the modernization of educational equipment, with significant funding support for updating outdated teaching and research devices. The "Implementation Plan for Major Equipment Updates in the Education Sector" aims to enhance educational quality and research capabilities [38]. Competitive Landscape - The educational instrument manufacturing industry features multiple tiers of companies, with leading firms like China Teaching Instrument Equipment Co., Ltd. and Zhejiang Qiushi Science Education Equipment Co., Ltd. dominating the market. The industry is characterized by regional disparities and a historical prevalence of family-run businesses [42][44].
企业竞争图谱:2024年六维力矩传感器 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2024-09-25 12:00
Investment Rating - The report rates the six-dimensional torque sensor industry with a 4-star rating, indicating a positive outlook for investment opportunities in this sector [32]. Core Insights - The six-dimensional torque sensor is a high-precision measuring instrument with increasing market demand, particularly in high-end equipment manufacturing. The Chinese market is currently dominated by foreign companies, but the pace of domestic production is accelerating, leading to intense competition and high market concentration. The industry has high technical barriers, involving complex production technologies and force control algorithms. Future growth is expected to be driven by the rising demand for humanoid robots and supportive policies, with the market projected to maintain rapid growth from 2025 to 2028 [4][10][32]. Industry Definition - Six-dimensional torque sensors are designed to measure three forces and three torques in three-dimensional space, combining mechanics and electronics to convert physical quantities into electrical signals for high-precision measurement [5]. Industry Characteristics - **Market Demand Growth**: The market demand for six-dimensional torque sensors is robust, driven by the transformation of global manufacturing and advancements in robotics, particularly in smart manufacturing and industrial automation [9][10]. - **Foreign Market Dominance**: Foreign companies currently hold about 70% of the Chinese market share, with domestic manufacturers accounting for approximately 30%. Domestic firms are increasing R&D investments to improve product quality and competitiveness [10][43]. - **High Entry Barriers**: The industry has high technical difficulty across all stages, requiring advanced manufacturing processes and significant capital investment [11]. - **Intense Competition**: The market is characterized by high concentration, with a few companies holding significant market shares. The competition is expected to intensify as domestic brands improve their capabilities [12][43]. Development History - The six-dimensional torque sensor industry has evolved through three stages: inception (1974-1990), initiation (1990-2020), and rapid development (2020-present). The current phase is marked by significant demand growth, particularly in robotics and industrial automation [13][16]. Industry Chain Analysis - **Upstream**: The upstream segment includes raw materials and component manufacturing, which directly impacts the performance of the sensors. Key materials include strain gauges and elastic bodies [17][18]. - **Midstream**: The midstream focuses on the manufacturing of six-dimensional torque sensors, where precision in assembly and testing is crucial [24]. - **Downstream**: The downstream applications span various industries, including industrial robotics, humanoid robots, aerospace, and medical fields, with humanoid robots expected to drive significant future demand [27][28]. Market Size - The market size for the six-dimensional torque sensor industry is projected to grow from 0.81 billion RMB in 2019 to 14.74 billion RMB by 2025, with a compound annual growth rate (CAGR) of 62.27%. From 2026 to 2028, the market is expected to expand from 24.28 billion RMB to 70.28 billion RMB, with a CAGR of 70.12% [32]. Competitive Landscape - The competitive landscape is characterized by a few leading companies, with the top 10 firms holding nearly 70% of the market share. Key players include ATI, Yuli Instruments, and Kunwei Technology, with domestic brands gradually closing the gap with international competitors [43][44].
中国自发光显示面板行业市场规模测算逻辑模型 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2024-09-25 11:40
Investment Rating - The report does not explicitly state an investment rating for the self-emissive display panel industry Core Insights - The self-emissive display panel market in China is projected to grow from CNY 1,653.8 billion in 2022 to CNY 2,646.02 billion by 2027, reflecting a compound annual growth rate (CAGR) of approximately 9.44% [22][31] - The OLED display panel market is expected to see significant growth, with the market size increasing from CNY 641.3 billion in 2022 to CNY 861.62 billion by 2027, indicating a CAGR of about 4.47% [31][28] - The LED display panel market is forecasted to recover from a decline in 2022, with an expected growth from CNY 1,012.5 billion in 2022 to CNY 1,784.4 billion by 2027, achieving a steady CAGR of 12% [22][38] Summary by Sections 1. Market Size Overview - The self-emissive display panel market in China is projected to reach CNY 1,856.89 billion in 2023, with a growth rate of 12.28% compared to the previous year [22] - The OLED segment is expected to grow significantly, with a forecast of CNY 722.89 billion in 2023, marking a growth rate of 12.72% [31] - The LED segment is anticipated to grow to CNY 1,134 billion in 2023, with a growth rate of 12% [38] 2. Global AMOLED Display Panel Shipment - Global shipments of AMOLED display panels are projected to increase from 922 million units in 2022 to 1,144 million units by 2027, with a steady growth rate of around 4.38% [23] 3. PMOLED Display Panel Global Market Size - The PMOLED market is expected to grow from USD 255 million in 2022 to USD 411 million by 2027, with a CAGR of approximately 9.89% [24] 4. Global OLED Display Panel Market Size - The global OLED display panel market is projected to grow from USD 9,625 million in 2017 to USD 23,291 million by 2027, reflecting a CAGR of about 4.47% [26] 5. China's OLED Display Panel Market Size - The Chinese OLED display panel market is expected to grow from USD 48.13 million in 2017 to USD 12,810.05 million by 2027, with a significant growth rate of 4.47% [31] 6. Exchange Rate Impact - The USD to CNY exchange rate is projected to remain stable around 6.73 from 2023 to 2027, which may impact the pricing and competitiveness of imported display panels [30]
2024年中国心脑血管健康保健食品行业概览报告
Tou Bao Yan Jiu Yuan· 2024-09-24 12:31
Investment Rating - The report does not explicitly state an investment rating for the cardiovascular health food industry in China Core Insights - The cardiovascular health food industry in China is experiencing rapid growth driven by an aging population and increasing health awareness among consumers. The potential for growth in cardiovascular health food products is expected to be rapidly released with policy support [3][6] - The demand for cardiovascular health food products is rising as the public becomes more aware of the health risks associated with hypertension, hyperlipidemia, and hyperglycemia, which are major risk factors for cardiovascular diseases [4][18] - The industry is characterized by a dual-track registration and filing system for health food products, which enhances the flexibility of new product launches and standardizes the industry [21][23] Summary by Sections Industry Overview - Cardiovascular diseases, including coronary heart disease and stroke, are prevalent, with "three highs" (hypertension, hyperlipidemia, and hyperglycemia) being significant risk factors [15][16] - The industry has evolved from disorderly to orderly, with improved regulatory frameworks and market standardization, currently in a phase of high-quality development [21][22] Market Size - The market size for cardiovascular health food products in China grew from 142.56 billion yuan in 2019 to 158.39 billion yuan in 2023, with projections to reach 189.89 billion yuan by 2028 [27][28] - The middle-aged and elderly markets are expanding due to increased health awareness and the aging population, respectively [26][29] Industry Chain Analysis - The industry chain consists of upstream raw material suppliers, midstream manufacturers, and downstream sales channels [33] - Traditional Chinese medicine is recognized as a significant source of raw materials for cardiovascular health products, with ingredients like ginseng, astragalus, and hawthorn being commonly used [36][38] Competitive Landscape - The industry is competitive, with a low concentration of market share and significant product homogeneity. Companies compete on product quality, innovation, brand building, and market positioning [46][47] - The growth potential of companies in this sector is influenced by their ability to innovate and control costs effectively [47]
工业级海绵锆:高性能材料,铸就石油化工安全基石 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2024-09-24 12:30
| --- | --- | --- | |--------|------------------|-------| | | | | | 2024年 | 头豹行业词条报告 | | Leadleo.com 工业级海绵锆:高性能材料,铸就石油化工安全基 石 头豹词条报告系列 孙越 · 头豹分析师 2024-08-23 未经平台授权,禁止转载 孙 行业: 制造业/有色金属冶炼和压延加工业/有色金属压延加工 原材料业/一般金属 版权有问题?点此投诉 | --- | --- | --- | --- | --- | --- | --- | |----------|--------------------------------------------------------------------------|----------|---------------------------------------------------------------------------------|------------------------------------------------------------------ ...
跨境电商ERP:供应链及营销能力有待提升,全球化多平台化成为发展重点 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2024-09-24 12:30
2024年 头豹行业词条报告 报告提供的任何内容(包括但不限于数据、文字、图表、图像等)均系头豹研究院独有的高度 机密性文件(在报告中另行标明出处者除外)。未经头豹研究院事先书面许可,任何人不得以 任何方式擅自复制、再造、传播、出版、引用、改编、汇编本报告内容,若有违反上述约定的 行为发生,头豹研究院保留采取法律措施、追究相关人员责任的权利。头豹研究院开展的所有 商业活动均使用"头豹研究院"或"头豹"的商号、商标,头豹研究院无任何前述名称之外的 其他分支机构,也未授权或聘用其他任何第三方代表头豹研究院开展商业活动。 Copyright © 2024 头豹 Leadleo.com 跨境电商ERP:供应链及营销能力有待提升,全球化 多平台化成为发展重点 头豹词条报告系列 付淑芳 · 头豹分析师 2024-09-06 未经平台授权,禁止转载 版权有问题?点此投诉 行业: 信息传输、软件和信息技术服务业/软件和信息技术服务业/其他信息技术服务业 信息科技/软件服务 | --- | --- | --- | --- | --- | --- | |----------|--------------------------- ...
中国人凝血因子Ⅷ行业市场规模测算逻辑模型 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2024-09-24 12:30
| --- | --- | --- | |----------------------------|------------------|-------| | | | | | | | | | | | | | | | | | 中国人凝血因子 | 行业市场规模测 | | | | 头豹词条报告系列 | | | 发布日期: 2024/09/13 荆婧 | | | 1. 中国人凝血因子Ⅷ市场规模 (结论图) P3 14. 溯源信息链接引用 P16 2. 中国人凝血因子Ⅷ市场规模 P4 15. 法律声明 P17 3. 中国血友病患病人数 P5 16. 头豹研究院简介 P18 4. 血友病用药渗透率 P6 17. 头豹词条介绍 P19 5. 血友病患者中用药治疗人数 P7 18. 头豹词条报告 P20 6. 用药患者中血友病A人数 P8 7. 血友病A患者单次用药成本 P9 8. 血友病A患者凝血治疗年成本 P10 9. 获得性血友病A现存患病人数 P11 10. 获得性血友病A患者中存在严重出血的病例占比 P12 11. 严重出血患者人数 P13 12. 获得性血友病A患者用药治疗渗透率 P14 13. 获得性血友病A患 ...
中国人参类保健食品行业市场规模测算逻辑模型 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2024-09-23 13:42
| --- | --- | --- | --- | |----------------------------|--------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | 中国人参类保健食品行业市场规模 | | | | | 测算逻辑模型 头豹词条报告系列 | | | | 发布日期: 2024/09/04 钟琪 | | | | 1. 中国人参类保健食品的市场规模 (结论图) P3 14. 头豹研究院简介 P16 2. 中国人参类保健食品的市场规模 P4 15. 头豹词条介绍 P17 3. 中国总人口数量 P5 16. 头豹词条报告 P18 4. 中国中老年人口比例 P6 5. 中国保健食品渗透率 P7 6. 中国人参保健食品与整体保健食品渗透率的相对乘数 P8 7. 中国人参保健食品渗透率 P9 8. 中国人参保健食品的消费客群数量 P10 9. 中国人参保健食品人均消费频次 P11 10. 中国人参保健食品的销售数量 P12 11. 中国人参保健食品的平均销售价格 ...
企业竞争图谱:2024年按摩仪器 头豹词条报告系列
Tou Bao Yan Jiu Yuan· 2024-09-23 13:41
2024年 头豹行业词条报告 报告提供的任何内容(包括但不限于数据、文字、图表、图像等)均系头豹研究院独有的高度 机密性文件(在报告中另行标明出处者除外)。未经头豹研究院事先书面许可,任何人不得以 任何方式擅自复制、再造、传播、出版、引用、改编、汇编本报告内容,若有违反上述约定的 行为发生,头豹研究院保留采取法律措施、追究相关人员责任的权利。头豹研究院开展的所有 商业活动均使用"头豹研究院"或"头豹"的商号、商标,头豹研究院无任何前述名称之外的 其他分支机构,也未授权或聘用其他任何第三方代表头豹研究院开展商业活动。 Copyright © 2024 头豹 Leadleo.com 企业竞争图谱:2024年按摩仪器 头豹词条报告系 列 许哲玮 · 头豹分析师 2024-08-23 未经平台授权,禁止转载 行业: 制造业/家具制造业 消费品制造 版权有问题?点此投诉 | --- | --- | --- | --- | --- | --- | |----------|------------------------------------------------------------------------|--- ...